Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Church & Dwight

Imperial Oil

Ramaco Resources

PACCAR

PACCAR Inc (PCAR), Church & Dwight Co., Inc. (CHD), Imperial Oil Limited (IMO), Ramaco Resources, Inc. (METC) and The Cigna Group (CI) recently hiked their dividends.

5 Stocks to Watch That Recently Announced Dividend Hikes

Lead Sponsor Cigna Healthcare Provided Free Biometric Health and Skin Cancer Screenings  to Faculty, Parents, and Community Members and Free Eye Exams and Glasses to PreK-5 Students  Zebra Technologies Sponsored Leave-Behind Mural Designed by Courtney "Yard$" Haywood  Joining the Team This Year are CBS Sports and Nickelodeon LAS VEGAS , Feb. 6, 2024 /PRNewswire/ -- Today, NFL legend and executive Troy Vincent, Sr. and his wife, Tommi A. Vincent, a renowned chef, podcast host, and philanthropist, hosted their seventh annual "Vincent Country Safe Zone Activity Day," a Love Thy Neighbor Community Development and Opportunity Corporation, at Matt Kelly Elementary School in Las Vegas, NV during Super Bowl LVIII Week.

SEVENTH ANNUAL "VINCENT COUNTRY SAFE ZONE ACTIVITY DAY" THEMED DREAM BIGGER, ACHIEVE GREATER HELD AT MATT KELLY ELEMENTARY DURING SUPER BOWL LVIII WEEK IN LAS VEGAS, NV

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?

The Cigna Group Ranks #1 in the Health Care Industry BLOOMFIELD, Conn. , Feb. 5, 2024 /PRNewswire/ -- The Cigna Group (NYSE: CI) ranks #6 in America for its leadership as a corporate citizen—jumping 10 spots from last year—on the newly released list of  Most JUST Companies  by JUST Capital and CNBC.

The Cigna Group Named No. 6 Among Best Corporate Citizens by JUST Capital and CNBC

BLOOMFIELD, Conn., Feb. 5, 2024 /PRNewswire/ -- The Cigna Group (NYSE: CI) announced today that it has commenced tender offers to purchase for cash (1) any and all of The Cigna Group's (the " Company ") 3.50% Senior Notes due 2024 and Evernorth Health, Inc.'s (" Evernorth ") 3.50% Senior Notes due 2024 (collectively, the " Any and All Notes ," and such tender offer, the " Any and All Tender Offer ") and (2) up to $1,250,000,000  aggregate principal amount (the " Maximum Tender Offer Amount ") of the Company's 4.125% Senior Notes due 2025, the Company's 4.500% Senior Notes due 2026, Evernorth's 4.500% Senior Notes due 2026, the Company's 1.250% Senior Notes due 2026, the Company's 3.050% Senior Notes due 2027, Cigna Holding Company's 3.050% Senior Notes due 2027 and the Company's 2.400% Senior Notes due 2030 (collectively, the " Maximum Tender Offer Notes ," and such tender offer, the " Maximum Tender Offer "), in each case, validly tendered and accepted by the Company, upon the terms and subject to the conditions set forth in the Offer to Purchase dated February 5, 2024 (the " Offer to Purchase ").

The Cigna Group Announces Commencement of Tender Offers for up to $2.25 Billion in Aggregate Principal Amount of Outstanding Notes

Allegion

Domino's Pizza

Elevance Health Inc

EOG Resources

Mastercard

Microchip Technology

MarketAxess Holdings

MSCI

Rollins

Sirius XM Holdings Inc

SPDR S&P 500 ETF Trust

SS&C Technologies Hlds

UnitedHealth Group

Visa

Vanguard Dividend Appreciation ETF

Zoetis

The SPDR S&P 500 ETF Trust had a 1.59% return in January, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for February 2024 offer an average dividend yield of 1.43% and appear to be about 29% undervalued based on dividend yield theory.

Top 15 High Growth Dividend Stocks For February 2024

Archer-Daniels-Midland Company

American Homes 4 Rent

Ares Capital

Bristol-Myers

Bank of Nova Scotia

British American Tobacco

Crown Castle International

Cincinnati Financial

CME Group

Chevron

Deere & Company

Dick's Sporting Goods

Enbridge

W.W. Grainger

Hershey

Johnson & Johnson

JPMorgan Chase & Co

Lennar

Mosaic

MPLX

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields just over 3%, we present two other groups of five DGI stocks each, with the goal of moderate to high yields.

5 Relatively Secure And Cheap Dividend Stocks To Invest In - February 2024

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has placed under review with developing implications the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” (Excellent) for several of The Cigna Group's Medicare entities, including those that focus on Medicare Advantage, Medicare Supplement, Medicare Part D and certain Cigna health maintenance organizations. Concurrently, AM Best also has placed under review with developing implications the FS.

AM Best Places Credit Ratings for Several Subsidiaries of The Cigna Group Under Review with Developing Implications

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Credit Ratings (ratings) of Health Care Service Corporation, a Mutual Legal Reserve Company (d/b/a Blue Cross Blue Shield of Illinois/Texas/New Mexico/Oklahoma/Montana) (HCSC) (headquartered in Chicago, IL) and its subsidiaries (see listing below) remain unchanged following its announcement that it has entered into a definitive agreement to acquire all of The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] Medicar.

AM Best Comments on Health Care Service Corporation's Planned Acquisition of The Cigna Group's Medicare Business

Cigna (CI) expects adjusted revenues to register a minimum growth of 20.3% from the 2023 reported figure.

Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up

Shares of The Cigna Group (CI) rose to their highest level in more than a year after the health insurance company posted better-than-expected results, raised its earnings guidance and boosted its dividend as it added pharmacy and medical plan customers.

Cigna's Stock Surges on Q4 Results, Guidance and Dividend Boost

The Cigna Group (CI) Q4 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Cigna (CI) Q4 Earnings: A Look at Key Metrics

A positive market reaction to managed-care financial results hasn't been the norm these past few week.

Cigna Gains After Earnings

Cigna (CI) came out with quarterly earnings of $6.79 per share, beating the Zacks Consensus Estimate of $6.52 per share. This compares to earnings of $4.96 per share a year ago.

Cigna (CI) Surpasses Q4 Earnings and Revenue Estimates

Shares of Cigna Group CI, +2.12% shot up 4% toward a 13-month high in premarket trading Friday, after the health care services company reported a fourth-quarter earnings beat and raised its dividend by 14%, as pharmacy and medical customers climbed. Net income came in at $2 billion, or $3.49 a share, after $1.53 billion, or $3.91 a share, in the year-go period.

Cigna stock jumps toward a 13-month higher after profit and revenue beats, raised dividend

Health insurer Cigna Group raised its 2024 profit forecast on Friday after lower-than-expected medical costs and strong demand in its pharmacy benefit management unit helped it beat fourth-quarter profit estimates.

Cigna raises 2024 profit view, beats Q4 earnings estimates on lower costs

BLOOMFIELD, Conn. , Feb. 2, 2024 /PRNewswire/ -- Total revenues for 2023 were $195.3 billion Shareholders' net income for 2023 was $5.2 billion, or $17.39 per share Adjusted income from operations1 for 2023 was $7.4 billion, or $25.09 per share 2024 adjusted income from operations1,2 is projected to be at least $8.025 billion, or at least $28.25 per share2 Board of Directors declared a 14% increase in the quarterly dividend to $1.40 per share Global health company The Cigna Group (NYSE: CI) today reported strong 2023 results reflecting revenue and earnings growth across its diversified portfolio of businesses.

The Cigna Group Reports Strong Fourth Quarter and Full Year 2023 Results, Raises 2024 Adjusted EPS Outlook, and Increases Dividend

Cigna Grou p (NYSE:CI)  will report fourth-quarter earnings before the open on Friday, Jan. 2.

Bullish Trendline Could Support Cigna Stock After Earnings

BLOOMFIELD, Conn. , Jan. 31, 2024  /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will be hosting its Investor Day on Thursday, March 7, 2024 in New York City.

The Cigna Group to Host Investor Day in New York City on March 7

Transaction Expected to be Accretive to Adjusted EPS1 in 2025 The Cigna Group Reaffirms 2024 Outlook and Long-Term Adjusted EPS1 Growth Target of 10-13% BLOOMFIELD, Conn. , Jan. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today announced that it has entered into a definitive agreement whereby Health Care Service Corporation (HCSC) will acquire The Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses, for a total transaction value of approximately $3.7 billion.

The Cigna Group to Sell Medicare Businesses and CareAllies to Health Care Service Corporation (HCSC)

Cigna Group CI, +0.02% has agreed to sell its Medicare Advantage business to Health Care Service Corp. for $3.3 billion in cash, the Wall Street Journal reported on Wednesday. Under the terms of the deal, HCSC , a nonprofit insurer, will acquire Cigna's Medicare lines, including Medicare Advantage, Medicare supplement and Medicare drug plans, as well as a unit called CareAllies that works with physician groups and other healthcare providers.

Cigna to sell Medicare Advantage business to Health Care Service for $3.3 billion in cash: WSJ

Cigna has agreed to sell its Medicare business to Health Care Service Corp for $3.3 billion in cash, the Wall Street Journal reported on Wednesday.

Cigna to sell Medicare business to Health Care Service for $3.3 bln - WSJ

The Cigna Group is selling its Medicare health benefits businesses and a medical care provider services operation for $3.3 billion to Health Care Service Corp., the parent of five Blue Cross and Blue Shield plans.

News for Cigna Stock (CI)